<DOC>
	<DOC>NCT01830205</DOC>
	<brief_summary>The purpose of this study is to assess the effect of renal function impairment on the single dose pharmacokinetics of Daclatasvir.</brief_summary>
	<brief_title>Pharmacokinetic and Safety Study of Daclatasvir in Patients With Renal Impairment</brief_title>
	<detailed_description>Treatment, Parallel Assignment, Open Label, Non-Randomized, Single Dose Adaptive Design, Pharmacokinetics Study</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Meet renal function criteria in one of four categories Unstable or uncontrolled medical conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>